OR WAIT null SECS
© 2023 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Penn Pharma's equipment addition meets growing need for continuous dry granulation and for handling of highly potent drugs.
Pharmaceutical manufacturer, Penn Pharma, a PCI company, has invested in a contained Gerteis Mini-Pactor for roller compaction of oral solid-dosage drugs containing potent APIs at its Tredegar site in South Wales, the company announced on Mar. 11, 2015.
Roller compaction provides a granulation method for materials that are heat and moisture sensitive, and avoids the use of liquid and high temperatures associated with wet granulation and subsequent drying methods. The Gerteis Mini-Pactor design enhances powder flow and offers effective containment using skan isolator technology and integrated cleaning systems. The process is easily scalable.
"We have recognized and responded to a growing need within the industry for continuous granulation methods by developing our dry granulation capabilities," said Mark Dean-Netscher, vice-president of International Operations at Penn Pharma, in the press release. "This roller compactor can be used from 1-kg development scale up to 100 kg/h at production scale, without the need for additional scale-up work. This will significantly reduce our clients' costs and allow products to be developed and delivered to market far quicker."
Source: Penn Pharma